Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 419-426

  Rice, William G ^a   Baker, David C ^b   Schaeffer, Catherine A ^a   Graham, Lisa ^a   Bu, Ming ^a   Terpening, Sara ^a   Clanton, David ^a   Schultz, Robert ^c   Bader, John P ^c   Buckheit Jr , Robert W ^d   Field, Lamar ^e   Singh, P K ^e   Turpin, Jim A ^a  

^a SAIC FREDERICK INC   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d SOUTHERN RESEARCH INSTITUTE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BENZAMIDE DERIVATIVE; CAPSID PROTEIN; DISULFIDE; GLUTATHIONE; NSC 624151; UNCLASSIFIED DRUG; VIRUS DNA; ZINC FINGER PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ADSORPTION; VIRUS INHIBITION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

EID: 0031050622     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.419     Document Type: Article

References (53)

1. Albouker, J. P., and A. M. Swart. 1993. Preliminary analysis of the Concorde trial. Lancet 341:889-890.
2. Aldovini, A., and R. A. Young. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
3. Bader, J. P., J. B. McMahon, R. J. Schultz, V. L. Narayanan, J. B. Pierce, O. S. Weislow, C. F. Midelfort, S. F. Stinson, and M. R. Boyd. 1991. Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction. Proc. Natl. Acad. Sci. USA 88:6740-6744.
4. Berg, J. M. 1986. Potential metal-binding domains in nucleic acid binding proteins. Science 232:485-487.
5. Berg, J. M., and Y. Shi. 1996. The galvanization of biology: a growing appreciation for the roles of zinc. Science 271:1081-1085.
6. Bowles, N. E., P. Damay, and P.-F. Spahr. 1993. Effect of rearrangement and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67:623-631.
7. Buckheit, R. W., Jr., J. L. Roberson, C. Lackman-Smith, J. R. Wyatt, T. A. Vickers, and D. J. Ecker. 1994. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). AIDS Res. Hum. Retroviruses 10:1497-1506.
8. Buckheit, R. W., Jr., T. L. Kinjerski, V. Fliakas-Boltz, J. D. Russell, T. L. Stup, L. A. Pallansch, W. G. Brouwer, D. C. Dao, W. A. Harrison, R. J. Schultz, J. P. Bader, and S. S. Yang. 1995. Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type 1-specific compounds related to oxathiin carboxanilide. Antimicrob. Agents Chemother. 39:2718-2727.
9. Chance, M. R., I. Sagi, M. D. Wirt, S. M. Frisbie, E. Scheuring, E. Chen, J. Bess, Jr., L. E. Henderson, L. O. Arthur, T. L. South, G. Perez-Alvarado, and M. F. Summers. 1992. Extended X-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc. Proc. Natl. Acad. Sci. USA 89:10041-10045.
10. Clanton, D. J., R. A. Moran, J. B. McMahon, O. S. Weislow, R. W. Buckheit, Jr., M. G. Hollingshead, V. Ciminale, B. K. Felber, G. N. Pavlakis, and J. P. Bader. 1992. Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action. J. Acquired Immune Defic. Syndr. 5:771-781.
11. Clanton, D. J., R. W. Buckheit, Jr., S. J. Terpening, R. Kisen, N. Mongelli, L. Lombardi Borgia, R. Schultz, V. Narayanan, J. P. Bader, and W. G. Rice. 1995. Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV. Antiviral Res. 27:335-354.
12. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
13. Cushman, M., W. M. Golebiewski, J. B. McMahon, R. W. Buckheit, Jr., D. J. Clanton, O. Weislow, R. D. Haugwitz, J. Bader, L. Graham, and W. G. Rice. 1994. Design, synthesis and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus replication. J. Med. Chem. 37:3040-3050.
14. Darlix, J.-L., A. Vincent, C. Gabus, H. De Rocquigny, and B. Roques. 1993. Trans-activation of the 5′ to 3′ viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV-1 RNA. C. R. Acad. Sci. III 316:763-771.
15. Déméné, H., C. Z. Dong, M. Ottmann, M. C. Rouyez, N. Jullian, N. Morellet, Y. Mely, J. L. Darlix, M. C. Fournié-Zaluski, S. Saragosti, and B. P. Roques. 1994. 1H NMR structure and biological studies of the His23→Cys mutant nucleocapsid protein of HIV-1 indicate that the conformation of the first zinc finger is critical for virus infectivity. Biochemistry 33:11707-11716.
16. Dorfman, T., J. Luban, S. P. Goff, W. A. Haseltine, and H. G. Göttlinger. 1993. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67:6159-6169.
17. Dreyer, G. B., B. W. Metcalf, T. A. Tomaszek, Jr., T. J. Carr, A. C. Chandler III, L. Hyland, S. A. Fakhoury, V. W. Magaard, M. L. Moore, J. E. Strickler, C. Debouck, and T. D. Meek. 1989. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. Proc. Natl. Acad. Sci. USA 86:9752-9756.
18. Frederickson, C. J., E. J. Kasarskis, D. Ringo, and R. E. Frederickson. 1987. A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain. J. Neurosci. Methods 20:91-103.
19. Gorelick, R. J., D. J. Chabot, D. E. Ott, T. D. Gagliardi, A. Rein, L. E. Henderson, and L. O. Arthur. 1996. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J. Virol. 70:2593-2597.
20. Gorelick, R. J., D. J. Chabot, A. Rein, L. E. Henderson, and L. O. Arthur. 1993. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036.
21. Gorelick, R. J., L. E. Henderson, J. P. Hanser, and A. Rein. 1988. Point mutations of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. USA 85:8420-8424.
22. Graham, N. M. H., S. L. Zeger, L. P. Park, S. H. Vermund, R. Detels, C. R. Inaldo, and J. P. Phair. 1992. The effects on survival of early treatment of human immunodeficiency virus infection. N. Engl. J. Med. 326:1037-1042.
23. Henderson, L. E., T. D. Copeland, R. C. Sowder, G. W. Smythers, and S. Oroszlan. 1981. Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J. Biol. Chem. 256:8400-8406.
24. Henderson, L. E., M. A. Bowers, R. C. Sowder, S. A. Serabyn, D. G. Johnson, J. R. Bess, Jr., L. O. Arthur, D. K. Bryant, and C. Fenselau. 1992. Gag proteins of the highly replicative NM strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processing, and complete amino acid sequences. J. Virol. 66:1856-1865.
25. Kageyama, S., T. Mimoto, Y. Murakawa, M. Nomizu, J. Ford, Jr., T. Sbirasaka, S. Gulnik, J. Erickson, K. Takada, H. Hayashi, S. Broder, Y. Kiso, and H. Mitsuya. 1993. In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine. Artimicrob. Agents Chemother. 37:810-817.
26. Kaplan, A. H., and R. Swanstrom. 1991. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. USA 88:4528-4532.
27. McQuade, T. J., A. G. Tomasselli, L. Liu, V. Karacostas, B. Moss, T. K. Sawyer, R. L. Heinrikson, and W. G. Tarpley. 1990. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-1 like particle maturation. Science 247:454-456.
28. Meek, T. D., D. M. Lambert, G. B. Dreyer, T. J. Carr, T. A. Tomaszek, Jr., M. L. Moore, J. E. Strickler, C. Debouck, L. J. Hyland, T. J. Matthews, B. W. Metcalf, and S. R. Petteway. 1990. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature 343:90-92.
29. Mellors, J. W., B. A. Larder, and R. F. Schinazi. 1995. Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance. Int. Antiviral News 3:8-13.
30. Parker, W. B., E. L. White, S. C. Shaddix, L. J. Ross, R. W. Buckheit, Jr., J. M. Germany, J. A. Secrist, R. Vince, and W. M. Shannon. 1991. Mechanism of inhibition of human immunodeficiency virus reverse transcriptase and human DNA polymerases α, β, γ by the 5′-triphosphates of carbovir, 3′-azido-3′-deoxythymidine, 2′,3′-dideoxyguanosine, and 3′-deoxythymidine. A novel RNA template for the evaluation of antiviral drugs. J. Biol. Chem. 266:1754-1762.
31. Prichard, M., and C. J. Shipman. 1990. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 14:181-206.
32. Reardon, J. E., and W. H. Miller. 1990. Human immunodeficiency virus reverse transcriptase: substrate and inhibitor kinetics with thymdine 5′-triphosphate and 3′-azido-3′-deoxythymidine 5′-triphosphate. J. Biol. Chem. 265:20302-20307.
33. Rein, A., D. E. Ott, J. Mirro, L. O. Arthur, W. G. Rice, and L. E. Henderson. 1996. Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein. J. Virol. 70:4966-4972.
34. Rice, W. G., C. A. Schaeffer, B. Harten, F. Villinger, T. L. South, M. F. Summers, L. E. Henderson, J. W. Bess, Jr., L. O. Arthur, J. S. McDougal, S. L. Orloff, J. Mendeleyev, and E. Kun. 1993. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 361:473-175.
35. Rice, W. G., J. G. Supko, L. Malspeis, R. W. Buckheit, Jr., D. Clanton, M. Bu, L. Graham, C. A. Schaeffer, J. A. Turpin, J. Domagala, R. Gogliotti, J. P. Bader, S. M. Halliday, L. Coren, R. C. Sowder, II, L. O. Arthur, and L. E. Henderson. 1995. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270:1194-1197.
36. Rice, W. G., J. A. Turpin, L. O. Arthur, and L. E. Henderson. 1995. Highly conserved retroviral zinc fingers as targets for HIV-1 therapeutic management. Int. Antiviral News 3:87-89.
37. Rice, W. G., J. A. Turpin, C. A. Schaeffer, L. Graham, D. Clanton, R. W. Buckheit, Jr., D. Zaharevitz, M. F. Summers, A. Wallqvist, and D. G. Covell. 1996. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J. Med. Chem. 39:3606-3616.
38. Rice, W. G., C. A. Schaeffer, L. Graham, M. Bu, J. McDougal, S. L. Orloff, F. Villinger, M. Young, S. Oroszlan, M. R. Fesen, Y. Pommier, J. Mendeleyev, and E. Kun. 1993. The site of action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes Proc. Natl. Acad. Sci. USA 90:9721-9724.
39. Rice, W. G., L. O. Arthur, L. E. Henderson, and J. A. Turpin. 1996. Discovery and development of disulfide-substituted benzamides as candidate anti-HIV drugs. Int. Antiviral News 4:3-6.
40. Rice, W. G., and J. P. Bader. 1995. Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals. Adv. Pharmacol. 33:389-438.
41. Rice, W. G., and J. A. Turpin. Virus-encoded zinc fingers as targets for antiviral chemotherapy. Rev. Med. Virol., 6:187-199.
42. Roberts, N. A., J. A. Martin, D. Kinchington, A. V. Broadhurst, J. C. Craig, I. B. Duncan, S. A. Galpin, B. J. Handa, J. Kay, A. Krohn, R. W. Lambert, J. H. Merrett, J. S. Mills, K. E. B. Parkes, S. Redshaw, A. J. Ritchie, D. L. Taylor, G. J. Thomas, and P. J. Machin. 1990. Rational design of peptide-based HIV proteinase inhibitors. Science 248:358-361.
43. Rodriguez-Rodriguez, L., Z. Tsuchihashi, G. M. Fuentes, R. A. Bambara, and P. J. Fay. 1995. Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in Vitro. J. Biol. Chem. 270:15005-15011.
44. Seligmann, M., D. A. Warrell, J. P. Aboulker, C. Carbon, J. H. Darbysshire, J. Dormot, E. Eschwege, D. J. Girling, D. R. James, J. P. Levy, T. E. A. Peto, D. Schwartz, A. B. Stone, I. V. D. Weller, and R. Withnall. 1994. Concorde: MRT/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343:871-881.
45. South, T. L., P. R. Blake, R. C. Sowder III, L. O. Arthur, L. E. Henderson, and M. F. Summers. 1990. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistry 29: 7786-7789.
46. South, T. L., and M. F. Summers. 1990. Zinc fingers. Adv. Inorg. Biochem. Ser. 8:199-248.
47. St. Clair, M., C. A. Richards, T. Spector, K. J. Weinhold, W. H. Miller, A. Langlois, and P. A. Furman. 1987. 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob. Agents Chemother. 31:1972-1977.
48. Summers, M. F., L. E. Henderson, M. R. Chance, J. W. Bess, Jr., T. L. South, P. R. Blake, G. Perez-Alvarado, R. C. Sowder, D. R. Hare, and L. O. Arthur. 1992. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1:563-574.
49. Tanchou, V., C. Gabus, V. Rogemond, and J.-L. Darlix. 1995. Formation of stable and functional HIV-1 nucleoprotein complexes in vitro. J. Mol. Biol. 252:563-571.
50. Turpin, J. A., C. A. Schaeffer, S. J. Terpening, L. Graham, M. Bu, and W. G. Rice. Reverse transcription of human immunodeficiency virus type 1 is blocked by retroviral zinc finger inhibitors. Antiviral Chem. Chemother., in press.
51. Turpin, J. A., S. J. Terpening, C. A. Schaeffer, G. Yu, C. J. Glover, R. L. Felsted, E. A. Sausville, and W. G. Rice. 1996. Inhibitors of HIV-1 zinc fingers prevent normal processing of Gag precursors and result in the release of noninfectious virus particles. J. Virol. 70:6180-6189.
52. Yarchoan, R., R. W. Klecker, K. J. Weinhold, P. D. Markham, H. K. Lyerly, D. T. Durack, E. Gelmann, S. Nusinoff-Lehrman, R. M. Blum, D. W. Barry, G. M. Shearer, M. A. Fischl, C. M. Myers, and S. Broder. 1986. Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS and AIDS-related complex. Lancet i:575-580.
53. You, J. C., and C. S. McHenery. 1994. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269:31491-31495.